Single-cell investigations uncover interactions between TREM1-expressing myeloid cells and cancer-associated fibroblasts during colorectal cancer development - Summary - MDSpire
Advertisement
Single-cell investigations uncover interactions between TREM1-expressing myeloid cells and cancer-associated fibroblasts during colorectal cancer development
To investigate the interactions between TREM1-positive myeloid cells and ACTA2-positive cancer-associated fibroblasts (CAFs) in the tumor microenvironment of colorectal cancer (CRC), focusing on the role of SPP1 signaling and its implications for therapeutic strategies.
Key Findings:
TREM1-positive myeloid cells were enriched in tumor tissues and associated with late-stage differentiated TAMCs, suggesting a role in tumor progression.
ACTA2-positive CAFs exhibited TGF-β-driven activation programs linked to CRC progression, indicating their potential as therapeutic targets.
SPP1 signaling from TREM1-positive myeloid cells to ACTA2-positive CAFs was identified as a potential axis of stromal-immune crosstalk, highlighting a novel interaction in the TME.
Interpretation:
The study highlights the significant role of TREM1-positive myeloid cells and CAFs in shaping the immunosuppressive tumor microenvironment in MSS CRC, suggesting potential therapeutic targets that could enhance treatment efficacy.
Limitations:
The study is based on a limited sample size of eight patients, which may not fully represent the CRC population.
Further functional validation of the identified interactions and signaling pathways is needed to confirm their roles in CRC.
Conclusion:
Understanding the interactions between TREM1-positive myeloid cells and CAFs may provide insights into immune evasion mechanisms in CRC and inform future therapeutic strategies.
